We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
-12.03%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.32B
AUM Growth
+$267M
(+3.8%)
Cap. Flow
+$1.37B
Cap. Flow
% of AUM
18.68%
Top 10 Holdings %
Top 10 Hldgs %
27.6%
Holding
1,433
New
327
Increased
283
Reduced
238
Closed
555
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$306M |
| 2 |
Cigna
CI
|
+$151M |
| 3 |
Pacira BioSciences
PCRX
|
+$143M |
| 4 |
ENDP
Endo International plc
ENDP
|
+$120M |
| 5 |
Tenet Healthcare
THC
|
+$99.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESPR
Esperion Therapeutics
ESPR
|
+$64.7M |
| 2 |
BCR
CR Bard Inc.
BCR
|
+$62.4M |
| 3 |
Perrigo
PRGO
|
+$52.7M |
| 4 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
+$49.4M |
| 5 |
SKX
Skechers
SKX
|
+$47.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 50.8% |
| 2 | Financials | 7.09% |
| 3 | Consumer Discretionary | 5.97% |
| 4 | Energy | 5.17% |
| 5 | Industrials | 4.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
MBIA
MBI
$261M
| $296K | ﹤0.01% |
48,656
-37,499
| -44% | -$241K |
|
677
Rollins
ROL
$18.3B
| $295K | ﹤0.01% |
+24,728
| New | +$312K |
|
678
IPG Photonics
IPGP
$3.61B
| $294K | ﹤0.01% |
3,865
+1,165
| +43% | +$98.8K |
|
|
PHH
679
DELISTED
PHH Corporation
PHH
| $293K | ﹤0.01% |
+20,728
| New | +$406K |
|
680
LyondellBasell Industries
LYB
$20B
| $290K | ﹤0.01% |
3,476
-1,494
| -30% | -$133K |
|
|
YHOO
681
CALL
DELISTED
Yahoo Inc
YHOO
| $289K | ﹤0.01% |
+10,000
| New | +$347K |
|
682
State Street SPDR S&P Semiconductor ETF
XSD
$2.72B
| $286K | ﹤0.01% |
+7,581
| New | +$297K |
|
683
AGCO
AGCO
$7.15B
| $284K | ﹤0.01% |
+6,082
| New | +$311K |
|
|
K
684
DELISTED
Kellanova
K
| $284K | ﹤0.01% |
4,538
+704
| +18% | +$43.9K |
|
685
Kohl's
KSS
$2.17B
| $284K | ﹤0.01% |
+6,140
| New | +$345K |
|
686
Dick's Sporting Goods
DKS
$17.5B
| $281K | ﹤0.01% |
5,662
-6,748
| -54% | -$341K |
|
|
TMX
687
DELISTED
Terminix Global Holdings, Inc.
TMX
| $280K | ﹤0.01% |
12,477
-9,490
| -43% | -$227K |
|
688
Voya Financial
VOYA
$9.01B
| $279K | ﹤0.01% |
+7,200
| New | +$317K |
|
689
Vail Resorts
MTN
$5.32B
| $278K | ﹤0.01% |
+2,652
| New | +$287K |
|
690
American Airlines Group
AAL
$10.1B
| $277K | ﹤0.01% |
7,130
-112,870
| -94% | -$4.63M |
|
691
Coca-Cola Europacific Partners
CCEP
$48.3B
| $277K | ﹤0.01% |
5,719
-19,601
| -77% | -$954K |
|
692
Leidos
LDOS
$14.5B
| $277K | ﹤0.01% |
+6,700
| New | +$280K |
|
693
General Mills
GIS
$19.1B
| $276K | ﹤0.01% |
+4,913
| New | +$281K |
|
|
HOUS
694
DELISTED
Anywhere Real Estate
HOUS
| $276K | ﹤0.01% |
+7,347
| New | +$320K |
|
695
Gilead Sciences
GILD
$162B
| $275K | ﹤0.01% |
+2,800
| New | +$311K |
|
|
SIAL
696
DELISTED
SIGMA - ALDRICH CORP
SIAL
| $275K | ﹤0.01% |
1,977
-216,757
| -99% | -$30.2M |
|
697
Phillips 66
PSX
$84.9B
| $273K | ﹤0.01% |
3,551
-9,618
| -73% | -$764K |
|
|
DRE
698
DELISTED
Duke Realty Corp.
DRE
| $272K | ﹤0.01% |
+14,268
| New | +$273K |
|
|
AGN
699
CALL
DELISTED
Allergan plc
AGN
| $272K | ﹤0.01% |
+1,000
| New | +$307K |
|
700
Trex
TREX
$4.51B
| $270K | ﹤0.01% |
+32,368
| New | +$333K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q3 2015 Portfolio in Review
As of Q3 2015, Visium Asset Management held 1,433 positions worth $7.32B, up 3.8% from $7.05B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Visium Asset Management deployed $1.37B of net new capital in Q3 2015, opening 327 new positions and adding to 283 existing holdings. Its largest new stake was Allergan plc: 997,201 shares worth $271M.
By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 49% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Perrigo, an estimated $52.7M trimmed.
- Visium Asset Management's largest Q3 2015 buy was Allergan plc: 997,201 shares worth $271M.
- Visium Asset Management added most to Pacira BioSciences in Q3 2015, an estimated $143M increase.
- Visium Asset Management's biggest Q3 2015 reduction was Perrigo, cutting an estimated $52.7M.
- Visium Asset Management fully exited Esperion Therapeutics in Q3 2015, selling an estimated $64.7M.
- Visium Asset Management's ten largest holdings make up 28% of its $7.32B portfolio in Q3 2015.
- Visium Asset Management opened 327 new positions and closed 555 in Q3 2015.
- Visium Asset Management's portfolio value rose 3.8% quarter-over-quarter to $7.32B.
Based on Visium Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.